Effects of COVID-19-targeted non-pharmaceutical interventions on pediatric emergency department use: a quasi-experimental study interrupted time-series analysis in North Italian hospitals, 2017 to 2022.

COVID-19 epidemiology Diseases of the Respiratory System Interrupted Time Series regression analysis Non-Pharmaceutical Intervention Symptoms injury and poisoning mental disorders quasi-experimental design

Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2024
Historique:
received: 31 05 2024
accepted: 22 07 2024
medline: 15 8 2024
pubmed: 15 8 2024
entrez: 15 8 2024
Statut: epublish

Résumé

The use of Non-Pharmaceutical Interventions (NPIs) during the COVID-19 pandemic is debated. Understanding the consequences these measures may have on vulnerable populations including children and adolescents is important. This is a multicenter, quasi-experimental before-after study involving 12 hospitals of the North Italian Emilia-Romagna Region, with NPI implementation as the intervention event. The 3 years preceding NPI implementation (in March 2020) constituted the pre-pandemic phase. The subsequent 2 years were further subdivided into a school closure phase (SC) and a subsequent mitigation measures phase (MM) with milder restrictions. Interrupted Time Series (ITS) regression analysis was used to calculate PED Standardized Incidence Rate Ratios (SIRR) on the diagnostic categories exhibiting the greatest frequency and/or variation. In the 60 months of the study there were 765,215 PED visits. Compared to the pre-pandemic rate, overall PED presentations dropped by 58 and 39% during SC and MM, respectively. "Symptoms, signs and Ill-defined conditions," "Injury and poisoning" and "Diseases of the Respiratory System" accounted for 74% of the reduction. A different pattern was instead seen for "Mental Disorders," which exhibited the smallest decrease during SC, and is the only category which rose already at the end of SC. ITS analysis confirmed the strong decrease during SC (level change, IRR 0.17, 95%CI 0.12-0.27) and a significant increase in MM (slope change, IRR 1.23, 95%CI 1.13-1.33), with the sharpest decline (-94%) and rise (+36%) observed in the "Diseases of the Respiratory System" category. Mental Disorders showed a significant increasing trend of 1% monthly over the whole study period exceeding pre-pandemic levels at the end of MM. Females and adolescents showed higher increasing rates both in SC and MM. NPIs appear to have influenced PED attendance in different ways according to diagnostic categories, mirroring different mechanisms of action. These effects are beneficial in some cases and harmful in others, and establishing a clear balance between pros and cons is a difficult task for public health decision makers. The role of NPIs on PED use appropriateness deserves investigation. The rise in pediatric mental disorders independent of the pandemic makes interventions addressing these issues urgent.

Sections du résumé

Background UNASSIGNED
The use of Non-Pharmaceutical Interventions (NPIs) during the COVID-19 pandemic is debated. Understanding the consequences these measures may have on vulnerable populations including children and adolescents is important.
Methods UNASSIGNED
This is a multicenter, quasi-experimental before-after study involving 12 hospitals of the North Italian Emilia-Romagna Region, with NPI implementation as the intervention event. The 3 years preceding NPI implementation (in March 2020) constituted the pre-pandemic phase. The subsequent 2 years were further subdivided into a school closure phase (SC) and a subsequent mitigation measures phase (MM) with milder restrictions. Interrupted Time Series (ITS) regression analysis was used to calculate PED Standardized Incidence Rate Ratios (SIRR) on the diagnostic categories exhibiting the greatest frequency and/or variation.
Results UNASSIGNED
In the 60 months of the study there were 765,215 PED visits. Compared to the pre-pandemic rate, overall PED presentations dropped by 58 and 39% during SC and MM, respectively. "Symptoms, signs and Ill-defined conditions," "Injury and poisoning" and "Diseases of the Respiratory System" accounted for 74% of the reduction. A different pattern was instead seen for "Mental Disorders," which exhibited the smallest decrease during SC, and is the only category which rose already at the end of SC. ITS analysis confirmed the strong decrease during SC (level change, IRR 0.17, 95%CI 0.12-0.27) and a significant increase in MM (slope change, IRR 1.23, 95%CI 1.13-1.33), with the sharpest decline (-94%) and rise (+36%) observed in the "Diseases of the Respiratory System" category. Mental Disorders showed a significant increasing trend of 1% monthly over the whole study period exceeding pre-pandemic levels at the end of MM. Females and adolescents showed higher increasing rates both in SC and MM.
Conclusion UNASSIGNED
NPIs appear to have influenced PED attendance in different ways according to diagnostic categories, mirroring different mechanisms of action. These effects are beneficial in some cases and harmful in others, and establishing a clear balance between pros and cons is a difficult task for public health decision makers. The role of NPIs on PED use appropriateness deserves investigation. The rise in pediatric mental disorders independent of the pandemic makes interventions addressing these issues urgent.

Identifiants

pubmed: 39145166
doi: 10.3389/fpubh.2024.1439078
pmc: PMC11322479
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1439078

Investigateurs

Francesca Diodati (F)
Chiara Maria Palo (C)
Angela Miniaci (A)
Luca Bertelli (L)
Giovanni Biserni (G)
Angela Troisi (A)
Alessandra Iacono (A)
Federico Bonvicini (F)
Domenico Bartolomeo (D)
Andrea Trombetta (A)
Tommaso Zini (T)
Nicoletta de Paulis (N)
Cristina Forest (C)
Battista Guidi (B)
Francesca Di Florio (F)
Enrico Valletta (E)
Francesco Accomando (F)
Greta Ramundo (G)
Alberto Argentiero (A)
Valentina Fainardi (V)
Michela Deolmi (M)

Informations de copyright

Copyright © 2024 Puntoni, Maglietta, Caminiti, Miniaci, Lanari, Caramelli, Marchetti, De Fanti, Iughetti, Biasucci, Suppiej, Miceli, Ghizzi, Vergine, Aricò, Stella, Esposito and the Emilia-Romagna Paediatric COVID-19 network.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Matteo Puntoni (M)

Clinical and Epidemiological Research Unit, University-Hospital of Parma, Parma, Italy.

Giuseppe Maglietta (G)

Clinical and Epidemiological Research Unit, University-Hospital of Parma, Parma, Italy.

Caterina Caminiti (C)

Clinical and Epidemiological Research Unit, University-Hospital of Parma, Parma, Italy.

Angela Miniaci (A)

Pediatric Clinic, IRCCS Azienda Ospedaliera Universitaria di Bologna, Bologna, Italy.

Marcello Lanari (M)

Pediatric Emergency Unit, IRCCS Azienda Ospedaliera Universitaria di Bologna, Bologna, Italy.

Fabio Caramelli (F)

Pediatric Intensive Care Unit, IRCCS Azienda Ospedaliera Universitaria di Bologna, Bologna, Italy.

Federico Marchetti (F)

Pediatrics and Neonatology Unit, Ravenna Hospital, AUSL Romagna, Ravenna, Italy.

Alessandro De Fanti (A)

Paediatrics Unit, Santa Maria Nuova Hospital, AUSL-IRCCS of Reggio Emilia, Reggio Emilia, Italy.

Lorenzo Iughetti (L)

Pediatrics Unit, Department of Medical and Surgical Sciences of Mothers, Children and Adults, University of Modena and Reggio Emilia, Modena, Italy.

Giacomo Biasucci (G)

Pediatrics and Neonatology Unit, Guglielmo da Saliceto Hospital, Piacenza, Italy.
Department of Medicine and Surgery, University of Parma, Parma, Italy.

Agnese Suppiej (A)

Pediatric Clinic, University of Ferrara, Ferrara, Italy.

Andrea Miceli (A)

Pediatric Unit, Pavullo Hospital, AUSL Modena, Modena, Italy.

Chiara Ghizzi (C)

Paediatrics Unit, Maggiore Hospital, Bologna, Italy.

Gianluca Vergine (G)

Pediatric Clinic, Rimini Hospital, AUSL Romagna, Rimini, Italy.

Melodie Aricò (M)

Pediatric Unit, G.B. Morgagni - L. Pierantoni Hospital, AUSL Romagna, Forlì, Italy.

Marcello Stella (M)

Pediatric Unit, AUSL Romagna, Cesena, Italy.

Susanna Esposito (S)

Department of Medicine and Surgery, University of Parma, Parma, Italy.
Pediatric Clinic, University-Hospital of Parma, Parma, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH